MedTrace Logo

Evaluation of the EasySense System in Congestive Heart Failure

NCT03237923 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 47

Last updated 2021-02-05

No results posted yet for this study

Summary

The EasySense device is a non-invasive device designed to measure lung fluid in patients with Congestive Heart Failure (CHF). This study seeks to evaluate the efficacy of the EasySense system in measuring lung fluid volume.

Conditions

  • Congestive Heart Failure

Interventions

DEVICE

EasySense device

Implementation of EasySense device during hospitalization and daily post-discharge for thirty days.

Sponsors & Collaborators

  • National Institutes of Health (NIH)

    collaborator NIH

  • University of Memphis

    collaborator OTHER

  • Ohio State University

    lead OTHER

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-07-01
Primary Completion
2019-06-30
Completion
2020-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03237923 on ClinicalTrials.gov